|
关注：1
2013-05-23 12:21
求翻译：Stamulumab (MYO-029[1]) is an experimental myostatin inhibiting drug developed by Wyeth Pharmaceuticals for the treatment of muscular dystrophy (MD). Stamulumab was formulated and tested by Wyeth in Collegeville, Pennsylvania.[2] Myostatin is a protein that inhibits the growth of muscle tissue, stamulumab is a recombin是什么意思？ 待解决
 悬赏分：1
- 离问题结束还有
Stamulumab (MYO-029[1]) is an experimental myostatin inhibiting drug developed by Wyeth Pharmaceuticals for the treatment of muscular dystrophy (MD). Stamulumab was formulated and tested by Wyeth in Collegeville, Pennsylvania.[2] Myostatin is a protein that inhibits the growth of muscle tissue, stamulumab is a recombin
问题补充： |
|
2013-05-23 12:21:38
Stamulumab （ MYO- 029 [ 1 ] ）是由惠氏制药公司进行性肌营养不良症的治疗（ MD ）开发出一种实验性肌肉生长抑制素抑制药。
|
|
2013-05-23 12:23:18
Stamulumab (MYO-029 [1])是肌肉萎缩症(MD)的治疗的惠氏配药开发的一种实验myostatin禁止的药物。Stamulumab由惠氏公式化并且测试在Collegeville，宾夕法尼亚。[2] Myostatin是禁止肌肉组织成长的蛋白质， stamulumab是再组合人的抗体被设计束缚对和禁止myostatin的活动。[3]
|
|
2013-05-23 12:24:58
正在翻译，请等待...
|
|
2013-05-23 12:26:38
Stamulumab （MYO-029[1]) 是实验的肌肉生长抑制素抑制药物治疗肌营养不良症 （MD） 由惠氏制药公司开发。Stamulumab 制定并由惠氏科利奇维尔，宾夕法尼亚州测试。[2] 肌肉生长抑制素是一种蛋白质，能抑制肌肉组织的生长，stamulumab 是一种重组的人类抗体，旨在将绑定到和抑制肌肉生长抑制素的活性。[] 3
|
|
2013-05-23 12:28:18
正在翻译，请等待...
|
湖北省互联网违法和不良信息举报平台 | 网上有害信息举报专区 | 电信诈骗举报专区 | 涉历史虚无主义有害信息举报专区 | 涉企侵权举报专区
